General Biotechnology

The Industrialization of Exceptions: When Compounding Crosses the Line from Patient Care to Patent Theft

In today’s rapidly evolving pharmaceutical landscape, the line between compassionate patient care and intellectual property infringement is becoming increasingly blurred. The recent surge in compounded medications—customized formulations prepared by ph…

The Industrialization of Exceptions: When Compounding Crosses the Line from Patient Care to Patent Theft Read Post »

Uncategorized

The math of monopoly

In the complex world of pharmaceuticals, the term “monopoly” often conjures images of corporate greed and inflated drug prices. But beneath the headlines lies a nuanced mathematical reality that shapes the very fabric of drug innovation, access, and af…

The math of monopoly Read Post »

Biotechblog
Scroll to Top